Is Treace Medical Concepts Inc (TMCI) overvalued? · rev $209.4M
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
This page asks whether Treace Medical Concepts Inc (TMCI) looks expensive on cached numbers — not a short thesis.
Latest reported TMCI revenue for 2024-12-31 was $209.4M. Net income was -$55.7M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. TMCI currently screens at market cap $260.1M.
TMCI currently screens at market cap $260.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TMCI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TMCI stock page for the full model, not this heading.
Not investment advice.